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461luminal narrowing. Mild luminal narrowing of lesions of
intermediate angiographic severity on ICA may serve as
a surrogate for early-stage coronary atherosclerosis. This
hypothesis is strengthened by the ﬁndings that diffuse mild
angiographic luminal narrowing on ICA is associated with
reduced stress-induced myocardial blood ﬂow and abnormal
resistance of the epicardial coronary arteries even before
a high-grade segmental stenosis is apparent (1–3).
In part because of these ﬁndings, high-grade angiographic
luminal narrowing visualized at the time of ICA does not
reliably determine the hemodynamic signiﬁcance of coronary
lesions. In patients with intermediate coronary stenosis, clinical
decisionmaking often relies on supplemental functional testing
(4). Fractional ﬂow reserve (FFR) is a lesion-speciﬁc technique
to determine the hemodynamic signiﬁcance of a coronary
stenosis and is widely considered the gold standard for physi-
ological assessment of coronary stenoses.
Coronary computed tomography angiography (CTA) is a
noninvasive test that correlates favorably with ICA and
intravascular ultrasound for measures of the severity of
luminal stenosis and direct visualization of coronary athero-
sclerosis, respectively (5). Methods of measuring the severity
of luminal stenosis by coronary CTA, similar to ICA, include
percent diameter stenosis, percent area stenosis, minimal
lumen diameter (MLD), and minimal lumen area (MLA).
Measures of coronary atherosclerosis by coronary CTA
include aggregate plaque volume.
Although the extent of mild luminal angiographic nar-
rowing is associated with the increasing prevalence and
severity of global myocardial ischemia on myocardial
perfusion imaging, the degree to which measures of coronary
atherosclerosis contribute to this phenomenon is unknown.
Further, the association of coronary atherosclerosis and
ischemia in a lesion-speciﬁc fashion has not been evaluated
to date. To address these issues, we examined coronary CTA
measures of luminal arterial narrowing as well as cumulative
coronary atherosclerotic plaque burden to identify the optimal
methods for diagnosis of ischemia-causing lesions of inter-
mediate stenosis severity when compared with an invasive
FFR reference standard.Methods
Study patients. Fifty-eight consecutive patients from2centers
who underwent clinically indicated coronary CTA and were
visually observed to have a coronary CTA–determined isolated
intermediate diameter stenosis (30% to 69%) in the proximal or
mid-portion of a major epicardial coronary artery were studied.
Upon visual identiﬁcation of the intermediate stenosis,
quantitative coronary CTA assessment was performed as
described in the following text. Study patients underwent
ICA with intended FFR of the intermediate stenosis within
3 months of the coronary CTA. Exclusion criteria included
additional intermediate- or high-grade stenoses within the
same vessel. The institutional review board of the 2 studycenters approved the study, and
all patients provided written in-
formed consent.
Acquisition of coronary CTA.




Germany) or 320-detector rowCT
(AquilionOne, Toshiba, Otawara,
Japan) in direct accordance with
the Society of Cardiovascular
Computed Tomography guide-
lines on performance of coronary
CTA (6). All patients were treated
with nitroglycerin, and those with
a heart rate >65 beats/min were
treated with beta-blockers unless
contraindicated. An intravenous
bolus (60 to 90 ml) of contrast
agent (Omnipaque 350 mg/dl or
Visipaque 320 mg/dl; both from
GE Healthcare, Princeton, New
Jersey) was injected at a ﬂow rate of 6ml/s. The scan parameters
included64 0.625/0.750-mmcollimation, a tubecurrent time
product of 350 mAs per rotation, and a tube voltage of 100 or
120 kVp. Scanswere performedusing electrocardiogram-based
tube current modulation whenever possible or sequential
(prospective) image acquisition. Transaxial images were
reconstructed with 0.6-/0.75-mm slice thickness, 0.3- to 0.4-
mm slice increment, and a medium-smooth convolution
kernel. For the helical scan, the position of the reconstruction
window within the cardiac cycle was individually selected to
minimize artifacts. Motion-free datasets, typically in mid-
diastole, were collected for analysis. The estimated effective
radiation dose for coronary CTA ranged from 2 to 10 mSv
using the dose-length product with an organ-speciﬁc
conversion factor k of 0.014 mSv/mGy/cm (7).
ICA and FFR. Selective ICA was performed by standard
catheterization in accordance with the American College of
Cardiology guidelines for coronary angiography (8). FFR
was measured using a 0.014-inch pressure sensor tipped
guidewire (PressureWire, St. Jude Medical Systems, St.
Paul, Minnesota) as previously described (9). Hyperemia
was induced with intracoronary bolus administration (80 mg
in the left coronary artery, 40 mg in the right coronary artery)
or intravenous continuous infusion (140 mg/kg/min) of
adenosine (10). Intracoronary nitroglycerin was adminis-
tered immediately before measurement of FFR. In keeping
with prior multicenter studies, an FFR value 0.80 was
considered to indicate lesion-speciﬁc ischemia (11).
Coronary CTA data analysis. Coronary CTA was analyzed
in blinded fashion and manually performed by 2 Level
III experienced readers in accordance with the Society
of Cardiovascular Computed Tomography guidelines on
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462interpretation of coronary CTA (12). All studies were of
good or excellent quality and allowed for comprehensive
analysis of the coronary artery and atherosclerotic plaque
features. Study results were computed as the average of
2 readers. The technique for coronary CTA measures was
as follows. After centerline deﬁnition, contiguous cross-
sectional reconstructions were rendered using a slice thick-
ness of 1 mm on a dedicated 3-dimensional workstation
(AW Advantage, GE Healthcare) (13,14). To allow for
optimal and consistent detection of plaque and outer vessel
boundaries, the window width was set as 155% of the mean
intensity within the lumen and the window level was set at
65% of the mean intensity for each lesion, as previously
described (14,15). Diameter stenosis (%) and area stenosis
(%) were calculated using proximal and distal reference
segments, which were selected to be the most adjacent points
to the maximal stenosis in which there was minimal or no
plaque. MLD (mm) and MLA (mm2) were measured from
the long-axis and short-axis views of double-oblique recon-
structions at the site of the maximal stenosis, respectively.
Percent aggregate plaque volume was calculated as
follows. Outer vessel contours were identiﬁed and deﬁned
as the visualized border at which point low attenuationFigure 1 Sample Illustration of Plaque Measurements
This ﬁgure illustrates part of slices from plaque measures. (A) Multiplanar reformat of the
lumen diameter (MLD) and 55.6% diameter stenosis. Dashed bars demonstrate the foci o
plaque measurements for 4 sequential cross-sectional images is provided (B: green, C:
ROI), and plaque areas (vessel area – lumen area). The corresponding fractional ﬂow reser
(MLA) is 1.49 mm2 and area stenosis is 59.5% (E). Aggregate plaque volume was obtain
plaque volume. ROI ¼ region of interest.(epicardial fat) was observed; lumen areas were manually
traced in each cross section. Plaque area was computed as
the vessel area minus the lumen area of each cross section.
Aggregate plaque volume was obtained by summation of
all contiguous plaque areas from the coronary artery os-
tium to the distal portion of the lesion. Percent aggregate
plaque volume was calculated as the aggregate plaque
volume divided by the total vessel volume and reported as
percentage. Figure 1 depicts a sample illustration of plaque
measurements.
Statistical analysis. Continuous variables are expressed as
mean  SD. For comparison of 2 groups, Student t test or
Wilcoxon rank sum test was used as appropriate. Categorical
variables were compared using Pearson chi-square test or
Fisher exact test as appropriate. Correlations between coro-
nary CTA parameters and FFR were assessed by calculating
Pearson correlation coefﬁcient. Interobserver and intra-
observer variability of coronary CTA parameters was assessed
by intraclass correlation coefﬁcients (ICC) for absolute
agreement of single measures between consistent raters
(MedCalc version 12.4,MedCalc Software,Ostend, Belgium)
and Bland-Altman plots. Univariable logistic regression
analysis was performed to evaluate the relationship betweencoronary computed tomography angiography (CTA) demonstrates a 1.20 mm minimal
f cross-sectional analyses across the length of the lesion. A sample representation of
blue, D: pink, E: red), demonstrating vessel areas (white ROI), lumen areas (yellow
ve (FFR) tracing is also seen (F). At the most stenotic lesion, the minimal lumen area
ed by summation of all contiguous plaque areas and reported as percent aggregate
Table 1 Baseline Patient Characteristics (N ¼ 58)
Age, yrs 63  9
Male 45 (78)
Body mass index, kg/m2 25  2
Risk factors
Hypertension 36 (62)
Diabetes mellitus 9 (16)
Dyslipidemia 50 (86)
Current smoker 21 (36)
Angina pectoris 58 (100)
Distribution of vessel
Left anterior descending artery 37 (64)
Left circumﬂex artery 5 (9)
Right coronary artery 16 (27)
Values are mean  SD or n (%).
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463coronary CTA parameters and the presence of lesion-speciﬁc
ischemia, where standardized odds ratio (OR) coefﬁcients
were added to enable direct comparison of predictors. For the
multivariable logistic regression analysis,ORswere reported to
examine the percent aggregate plaque volume versus diameter
stenosis, area stenosis, MLA, and MLD individually.
To examine discrimination, area under the receiver oper-
ating characteristic curves (AUC) were constructed and
compared for different coronary CTA parameters using the
method described by DeLong et al. (16) for correlated data.
Wedetermined the optimalmethod of ischemia diagnosis and
discrimination and evaluated the net reclassiﬁcation
improvement (NRI) of this method compared with other
coronary CTA parameters (17). To deﬁne categories of risk of
lesion-speciﬁc ischemia, we utilized anatomic measures
of luminal stenosis severity to categorize lesions convention-
ally believed to be of low, intermediate, and high probability of
ischemia, deﬁned as <50%, 50% to 69%, and 70% for
diameter stenosis and area stenosis. For MLD, MLA, and
percent aggregate plaque volume, we used tertiles of these
categories to examine reclassiﬁcation of lesion-speciﬁc
ischemia. For NRI calculations, cases were deﬁned as
patients with lesion-speciﬁc ischemia (FFR 0.80) and
controls were deﬁned as those without lesion-speciﬁc
ischemia (FFR >0.80). Associations and differences with p
values <0.05 were considered signiﬁcant. Statistical analyses
were performed using Stata software (version 11, StataCorp
LP, College Station, Texas) except where otherwise noted.Table 2
Coronary Computed Tomography Angiog
a Function of FFR Value
All
(N ¼ 58)
Diameter stenosis, % 50.8  13.4
Area stenosis, % 58.9  18.6
Minimal lumen diameter, mm 1.5  0.5
Minimal lumen area, mm2 3.3  1.9
Percent aggregate plaque volume 43.0  7.9
FFR ¼ fractional ﬂow reserve.Results
Patient characteristics. We identiﬁed 58 intermediate
stenoses in 58 patients. The median intertest duration
between coronary CTA and FFR was 21 days (interquartile
range: 13 to 35 days), with no adverse clinical events, change
of symptoms, or coronary revascularization occurring bet-
ween coronary CTA and FFR. The baseline characteristics
of the study population are listed in Table 1. Intermedi-
ate lesions were most often present in the left anterior
descending artery (n ¼ 37), followed by the right coronary
artery (n ¼ 16) and then the left circumﬂex artery (n ¼ 5).
Twenty-two ischemic lesions (38%) were identiﬁed by FFR,
with an average FFR value of 0.82  0.10. Compared with
nonischemic lesions, ischemic lesions demonstrated no
differences in diameter stenosis or area stenosis but had
smaller MLD and MLA and greater percent aggregate
plaque volume (Table 2).
Correlation between coronary CTA parameters and
FFR. Moderate signiﬁcant correlations were observed
between FFR values and diameter stenosis (r ¼ 0.35,
p ¼ 0.007), area stenosis (r ¼ 0.39, p ¼ 0.003), MLD
(r ¼ 0.43, p ¼ 0.0009), MLA (r ¼ 0.47, p ¼ 0.0002), and
percent aggregate plaque volume (r ¼ 0.50, p <0.0001).
No correlation of percent aggregate plaque volume and
lesion length was observed (r ¼ 0.10, p ¼ 0.4).
Interobserver and intraobserver variability. Interobserver
variability for all lesions for measures of luminal narrowing
and atherosclerotic plaque was good to excellent with gen-
erally low limits of agreement as follows: percent aggregate
plaque volume: ICC 0.56, p < 0.0001, Bland-Altman bias
3.8%, limits of agreement 11.7% to 19.2%; diameter
stenosis: ICC 0.68, p < 0.0001, Bland-Altman bias 2.6%,
limits of agreement 25.3% to 20.1%; area stenosis: ICC
0.78, p < 0.0001, Bland-Altman bias 4.1%, limits of
agreement 28.9% to 20.7%.
Intraobserver variability for a randomly selected 20% of
lesions measured more than 60 days apart demonstrated
excellent correlation with low limits of agreement as follows:
percent aggregate plaque volume: ICC 0.99, p < 0.0001,
Bland-Altman bias 0.4%, limits of agreement 3.0%
to 2.3%; diameter stenosis: ICC 0.94, p < 0.0001, Bland-
Altman bias 1.9%, limits of agreement 12.3% to 8.5%;




(n ¼ 36) p Value
54.9  13.9 48.3  12.6 0.07
65.0  15.5 55.2  19.5 0.05
1.3  0.5 1.7  0.5 0.01
2.5  1.6 3.8  1.9 0.01
48.9  7.4 39.3  5.8 <0.0001
Table 3
Univariable Logistic Regression Analysis for Coronary






Odds Ratio p Value
Diameter stenosis 1.04 (0.99–1.09) 1.78 0.08
Area stenosis 1.03 (0.99–1.07) 1.87 0.06
Minimal lumen diameter 5.63 (1.29–24.6) 2.40 0.02
Minimal lumen area 1.91 (1.16–3.16) 3.34 0.01
Percent aggregate
plaque volume
1.23 (1.11–1.44) 6.46 0.0001
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4640.5%, limits of agreement 13.0% to 11.9% (Online
Fig. 1).
Diagnosis of lesion-speciﬁc ischemia by coronary
CTA. On univariable logistic regression analysis, MLD,
MLA, and percent aggregate plaque volume were signi-
ﬁcantly related to ischemia-causing intermediate lesions
(Table 3). On multivariable logistic regression analysis,
percent aggregate plaque volume remained a signiﬁcant
predictor for lesion-speciﬁc ischemia over diameter stenosis
(OR: 1.28; 95% conﬁdence interval [CI]: 1.12 to 1.47; p <
0.001), area stenosis (OR: 1.29; 95% CI: 1.12 to 1.49; p <
0.001), MLD (OR: 1.26; 95% CI: 1.11 to 1.43; p < 0.001),
and MLA (OR: 1.27; 95% CI: 1.10 to 1.47; p < 0.001).
Study results were unchanged when examined by particular
CT system.
Discrimination of ischemia of intermediate stenoses by
coronary CTA. The AUC for lesion-speciﬁc ischemia was
higher for percent aggregate plaque volume (0.85; 95% CI:
0.74 to 0.97) than for diameter stenosis (0.68; 95% CI: 0.54Figure 2 AUC for Discriminating Ischemic Lesions
AUC was highest for percent aggregate plaque volume (%APV) at 0.85 (A). The other AU
other parameters of coronary artery disease severity considered alone (B, C, and D), wit
characteristic curve; AS ¼ area stenosis; DS ¼ diameter stenosis. Abbreviations as in Fto 0.83), area stenosis (0.66; 95% CI: 0.51 to 0.80), MLD
(0.75; 95% CI: 0.61 to 0.88), or MLA (0.78; 95% CI: 0.64
to 0.91) (Fig. 2). On adjusted logistic regression analyses,
percent aggregate plaque volume provided incremental
prediction for lesion ischemia over diameter stenosis (AUC
0.88 [95% CI: 0.78 to 0.99] vs. 0.68 [95% CI: 0.54 to
0.83], respectively; p ¼ 0.02), area stenosis (0.88 [95% CI:
0.79 to 0.97] vs. 0.66 [95% CI: 0.51 to 0.80], respectively;
p ¼ 0.003), and MLD (0.90 [95% CI: 0.79 to 0.99] vs. 0.75
[95% CI: 0.61 to 0.88], respectively; p ¼ 0.03). Percent
aggregate plaque volume trended toward but did not
signiﬁcantly improve the discriminatory power over MLA
(0.89 [95% CI: 0.79 to 0.99] vs. 0.78 [95% CI: 0.64 to
0.91], respectively; p ¼ 0.07).
NRI of ischemic lesions. Percent aggregate plaque
volume enabled effective reclassiﬁcation of intermediate
ischemic lesions with measures of diameter stenosis (NRI
0.77; 95% CI: 0.41 to 1.12; p < 0.001), area stenosis (NRI
0.63; 95% CI: 0.27 to 0.99; p ¼ 0.002), MLD (NRI 0.62;
95% CI: 0.30 to 0.93; p ¼ 0.001), and MLA (NRI 0.43;
95% CI: 0.11 to 0.75; p ¼ 0.01) (Online Table 1).
Figures 3 and 4 show an example of coronary CTA
measures for an ischemic intermediate lesion and a non-
ischemic intermediate lesion, respectively.Discussion
In this study, we compared an array of CAD severity
measures by coronary CTA for the diagnosis of ischemia for
stenoses of intermediate severity. These quantitative measures
included diameter stenosis, area stenosis, MLD, and MLA.
Given the ability of coronary CTA to observe both luminalC graphs illustrate that %APV provided incremental discrimination of ischemia over
h the exception of MLA (E). *p < 0.05. AUC ¼ area under the receiver operating
igure 1.
Figure 3 Coronary CTA Measures and FFR of an Ischemic Vessel
(A)Multiplanar reformat of the coronary CTA demonstrates intermediate stenosis in the proximal left anterior descending artery (diameter stenosis 55.6%, area stenosis 59.5%,
MLD 1.2 mm, MLA 1.5 mm2). The FFR value at invasive coronary angiography was 0.50 (B), indicating vessel ischemia. The percent aggregate plaque volume (60.2%) was high,
indicating that 60.2% of the vessel volume from the ostium to the distal portion of the lesion was composed of plaque. Abbreviations as in Figure 1.
Figure 4 Coronary CTA Measures and FFR of a Nonischemic Vessel
(A) Multiplanar reformat of the coronary CTA demonstrates a 63.3% diameter stenosis and a 72.2% area stenosis in the mid left anterior descending artery (MLD 1.1 mm, MLA
1.9 mm2). The FFR value at invasive coronary angiography was 0.86 (B), indicating no ischemia. The percent aggregate plaque volume was 27.8%, a low value. Abbreviations as
in Figure 1.
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466narrowing and atherosclerotic plaque, we also evaluated
aggregate plaque volume, which considers the cumulative
atherosclerotic plaque burden from the vessel ostium to the
distal portion of a plaque causing a stenosis. We observed
that percent aggregate plaque volume allowed for diagnosis
of lesion-speciﬁc ischemia of intermediate stenoses in a
manner that surpasses more traditional angiographic measures
of CAD lesion severity and that, when combined with these
measures, offered independent and incremental discrimina-
tory power. The robustness of percent aggregate plaque
volume as an important marker of ischemia was evident for
all analyses, including diagnosis, correlation, discrimination,
and reclassiﬁcation.
Prior reports have consistently demonstrated that visual
assessment of lumen diameter stenosis, the most commonly
used method for determination of CAD severity, correlates
unreliably to the presence of hemodynamically signiﬁcant
stenoses. These ﬁndings have evoked concerns that reliance
on visualized measures of anatomic luminal narrowing alone
may encourage coronary revascularization of nonischemia-
causing coronary lesions. In contrast, non-negligible rates of
ischemia across coronary lesions not traditionally considered
angiographically severe have raised concerns that symp-
tomatic patients with ischemia may be missed. These ﬁnd-
ings hold true for stenoses visualized by both ICA as well as
coronary CTA and, in particular, for lesions of intermediate
severity even determined by quantitative measures (1,18–20).
The potential explanations for these ﬁndings are manifold.
Numerous additional factors may contribute to the induction
of ischemia across a coronary stenosis and include anatomic
factors, such as stenosis length or geometry, and physiological
factors, such as impaired hyperemic responses arising from
endothelial dysfunction or dynamic vasoconstriction. Directly
germane to the present study, diffuse atherosclerotic plaque
proximal to and involving a stenosis may also substantively
contribute to the ischemia-producing nature of a coronary
lesion, a ﬁnding that may result in the underestimation of
diameter stenosis and area stenosis severity, in particular for
ICA, by erroneous comparison of diseased segments to
angiographically normal-appearing segments that neverthe-
less are affected by atherosclerotic plaque (21).
Pathophysiologically, the totality of atherosclerosis prox-
imal to a coronary lesion has been demonstrated to be vital to
the contribution of ischemia. De Bruyne et al. (3) reported
that early-stage coronary atherosclerosis is often associated
with abnormal resistance of the epicardial coronary arteries
before a high-grade segmental stenosis is apparent at angi-
ography by ICA. In addition to the resistance caused by
focal stenosis or arteriolar vasomotor dysfunction, diffusely
atherosclerotic epicardial coronary arteries without high-
grade segmental stenoses often manifest a continuous pres-
sure decline along their length, reduce coronary ﬂow reserve,
and contribute to myocardial ischemia. These ﬁndings
suggest the importance of measuring the atherosclerotic
plaque in stenotic lesions as well as angiographically “normal”
lesions that may include diffuse atherosclerosis.To date, several prior efforts have attempted to examine
the ability of coronary CTA measures to identify lesion-
speciﬁc ischemia. In a recent study by Kristensen et al.
(22) of patients with intermediate stenoses undergoing
evaluation with both ICA and coronary CTA, traditional
quantitative coronary CTA parameters were better corre-
lated to hemodynamic signiﬁcance as compared with FFR.
Our ﬁndings are in general accordance with this study, and
we observed similar correlations between coronary CTA
parameters and FFR as compared with these investigations.
Nevertheless, our study directly builds on these important
results by inclusion not only of luminal narrowing measures
but the totality of atherosclerotic plaque volume proximal to
the narrowing as well. We observed that diffuse athero-
sclerosis that was mild in luminal narrowing contributes
signiﬁcantly to the ischemic process. Further, we observed
that the cumulative summation of atherosclerotic plaque
before a lesion not only performs superiorly to measures of
luminal narrowing but is also additive to luminal measures as
well. In this regard, combined use of percent aggregate
plaque volume and measures of luminal narrowing may
represent a more ideal approach to identifying lesions that
cause ischemia.
In this study, we restricted analysis to lesions of inter-
mediate stenosis severity as visualized by coronary CTA.
Anatomic measurement of luminal narrowing is difﬁcult for
these types of lesions, both by invasive and noninvasive
means, given that the conventional deﬁnitions of angio-
graphic severity for these lesions are at a point above which
considerable rates of ischemia are often identiﬁed. This issue
is underscored by the almost 40% of intermediate lesions in
the current study that were associated with ischemia, with
6 of 23 lesions (26%) with diameter stenosis <50% causing
ischemia.
Study limitations. This study is not without limitations.
This study was performed on a generally small sample.
Given the safety concerns of performing invasive FFR for
nonclinically indicated coronary lesions, we reserved anal-
ysis only for those for whom clinical indications such as
persistent angina drove the prospective performance of
invasive FFR. Further, we only examined stenoses of
intermediate severity, given the difﬁculty of diagnosing
ischemia for these lesions on the basis of angiographic
standards alone. This may have ampliﬁed the incremental
utility of percent aggregate plaque volume, which may be
signiﬁcantly less robust in lesions of higher or lower
stenosis severity. Future studies examining the relationship
of percent aggregate plaque volume to these types of
coronary lesions should be performed and are an active area
of investigation in our own laboratory. We also identiﬁed
intermediate coronary stenoses by visual assessment of
an expert reader at the time of coronary CTA interpreta-
tion. We did so to reﬂect a “real-world” design for prac-
titioners who often identify symptomatic patients with
stenoses that may not necessarily be considered anatomi-
cally severe. The clinical interpretations that drove the
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467included study sample were accurate, because the average
diameter stenosis was 50.8%, with 52 lesions (90%)
ranging between 30% and 69% diameter stenosis on
quantitative coronary CTA. Finally, manual plaque mea-
surements by coronary CTA, including those required to
calculate aggregate plaque volume, are time consuming and
necessitate expert interpretation. Whether the present
study results can be universally applied to practitioners
interpreting coronary CTA on a daily basis requires further
study. Because several automated methods for coronary
plaque quantiﬁcation have recently been introduced, these
software applications may allow for greater widespread
adoption of the current study ﬁndings.
Conclusions
For coronary lesions of intermediate stenosis severity,
percent aggregate atherosclerotic plaque volume is superior
as well as additive to traditional angiographic measures of
luminal narrowing for diagnosis, correlation, discrimination,
and reclassiﬁcation of ischemia.
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